May 21, 2018
1 min read

11 institutions join AACR Project GENIE Consortium

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Charles L. Sawyers

Eleven institutions have joined an American Association for Cancer Research-led effort designed to aggregate and link cancer genomic data with clinical outcomes.

The 11 new participants in AACR Project GENIE are Children’s Hospital of Philadelphia, Cancer Research UK Cambridge Centre at University of Cambridge, Duke University, Columbia University, Swedish Cancer Institute, Providence Cancer Institute, Wake Forest University Health Sciences, The University of Chicago, University of California, San Francisco, Vall d’Hebron Institute of Oncology, and Yale University.

There are now 19 institutions contributing clinical-grade genomic and clinical outcomes data to AACR Project GENIE registry.

“We are extremely excited to make good on our promise of adding new participating institutions to AACR Project GENIE,” Charles L. Sawyers, MD, FAACR, chairman of the AACR Project GENIE Steering Committee and chairman of the human oncology and pathogenesis program at Memorial Sloan Kettering Cancer Center, said in an AACR-issued press release. “In just 2 years, the founding institutions of the project have been able to accumulate and make public more than 39,000 deidentified genomic records. Now that we have more than doubled in size, we anticipate a substantial acceleration in the pace at which the registry will grow, increasing our ability to benefit patients even sooner.”

The initial eight participants in AACR Project GENIE were Dana-Farber Cancer Institute, Gustave Roussy Cancer Campus, The Netherlands Cancer Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Memorial Sloan Kettering Cancer Center, Princess Margaret Cancer Centre, The University of Texas MD Anderson Cancer Center and Vanderbilt-Ingram Cancer Center.